{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:32Z","timestamp":1790957612756,"version":"4.1.0"},"reference-count":245,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"Instituto de Salud Carlos III (ISCIII) and Fondos FEDER European Union","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"Red de Investigaci\u00f3n Renal REDINREN","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"European Union\u2014NextGenerationEU, Sociedad Espa\u00f1ola de Nefrolog\u00eda","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"European Union\u2019s Horizon 2020","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"European Union\u2019s Horizon 2020","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"European Union\u2019s Horizon 2020","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"European Union\u2019s Horizon 2020","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"European Union\u2019s Horizon 2020","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"European Union\u2019s Horizon 2020","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"European Union\u2019s Horizon 2020","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"European Union\u2019s Horizon 2020","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"European Union\u2019s Horizon 2020","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"Narodowe Centrum Nauki","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"Narodowe Centrum Nauki","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"Narodowe Centrum Nauki","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"Narodowe Centrum Nauki","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"Narodowe Centrum Nauki","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"Narodowe Centrum Nauki","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"Narodowe Centrum Nauki","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"Narodowe Centrum Nauki","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"Narodowe Centrum Nauki","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"Ministry for Health of Italy (Ricerca Corrente)","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["PI20\/00140"],"award-info":[{"award-number":["PI20\/00140"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["PI19\/00815"],"award-info":[{"award-number":["PI19\/00815"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["DTS20\/00083"],"award-info":[{"award-number":["DTS20\/00083"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["RD16\/0009\/0003"],"award-info":[{"award-number":["RD16\/0009\/0003"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["RICORS2040"],"award-info":[{"award-number":["RICORS2040"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["RD21\/0005\/0002"],"award-info":[{"award-number":["RD21\/0005\/0002"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["812699"],"award-info":[{"award-number":["812699"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["2018\/29\/N\/NZ3\/02504"],"award-info":[{"award-number":["2018\/29\/N\/NZ3\/02504"]}]},{"name":"Spanish Ministry of Science and Innovation\/Fondo Europeo de Desarrollo Regional (MICINN\/FEDER)","award":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID 2019-110132RB-I00\/AEI\/10.13039\/501100011033"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney replacement therapies (KRT). Peritoneal dialysis (PD) is a convenient KRT presenting benefices as home therapy. In PD patients, the peritoneum is chronically exposed to PD fluids containing supraphysiologic concentrations of glucose or other osmotic agents, leading to the activation of cellular and molecular processes of damage, including inflammation and fibrosis. Importantly, peritonitis episodes enhance peritoneum inflammation status and accelerate peritoneal injury. Here, we review the role of immune cells in the damage of the peritoneal membrane (PM) by repeated exposure to PD fluids during KRT as well as by bacterial or viral infections. We also discuss the anti-inflammatory properties of current clinical treatments of CKD patients in KRT and their potential effect on preserving PM integrity. Finally, given the current importance of coronavirus disease 2019 (COVID-19) disease, we also analyze here the implications of this disease in CKD and KRT.<\/jats:p>","DOI":"10.3390\/ijms24065763","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T04:33:31Z","timestamp":1679286811000},"page":"5763","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Novel Aspects of the Immune Response Involved in the Peritoneal Damage in Chronic Kidney Disease Patients under Dialysis"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7327-194X","authenticated-orcid":false,"given":"Flavia","family":"Trionfetti","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"},{"name":"Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases L., Spallanzani, IRCCS, Via Portuense, 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2767-0229","authenticated-orcid":false,"given":"Vanessa","family":"Marchant","sequence":"additional","affiliation":[{"name":"Cellular Biology in Renal Diseases Laboratory, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz-Universidad Aut\u00f3noma Madrid, 28040 Madrid, Spain"},{"name":"REDINREN\/RICORS2040, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-904X","authenticated-orcid":false,"given":"Guadalupe T.","family":"Gonz\u00e1lez-Mateo","sequence":"additional","affiliation":[{"name":"Cell-Cell Communication & Inflammation Unit, Centre for Molecular Biology \u201cSevero Ochoa\u201d (CSIC-UAM), 28049 Madrid, Spain"},{"name":"Premium Research, S.L., 19005 Guadalajara, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5846-6239","authenticated-orcid":false,"given":"Edyta","family":"Kawka","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Poznan University of Medical Sciences, 10 Fredry St., 61-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-1939","authenticated-orcid":false,"given":"Laura","family":"M\u00e1rquez-Exp\u00f3sito","sequence":"additional","affiliation":[{"name":"Cellular Biology in Renal Diseases Laboratory, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz-Universidad Aut\u00f3noma Madrid, 28040 Madrid, Spain"},{"name":"REDINREN\/RICORS2040, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[{"name":"IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz-Universidad Aut\u00f3noma Madrid, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-9719","authenticated-orcid":false,"given":"Manuel","family":"L\u00f3pez-Cabrera","sequence":"additional","affiliation":[{"name":"Cell-Cell Communication & Inflammation Unit, Centre for Molecular Biology \u201cSevero Ochoa\u201d (CSIC-UAM), 28049 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1495-6535","authenticated-orcid":false,"given":"Marta","family":"Ruiz-Ortega","sequence":"additional","affiliation":[{"name":"Cellular Biology in Renal Diseases Laboratory, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz-Universidad Aut\u00f3noma Madrid, 28040 Madrid, Spain"},{"name":"REDINREN\/RICORS2040, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-8381","authenticated-orcid":false,"given":"Raffaele","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"},{"name":"Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases L., Spallanzani, IRCCS, Via Portuense, 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ckj\/sfab170","article-title":"RICORS2040: The need for collaborative research in chronic kidney disease","volume":"15","author":"Ortiz","year":"2022","journal-title":"Clin. Kidney J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: Synopsis of the kidney disease: Improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","article-title":"Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA","volume":"36","author":"Council","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1523-1755.2005.67130.x","article-title":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","volume":"67","author":"Chu","year":"2005","journal-title":"Kidney Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3747\/pdi.2014.00038","article-title":"Biocompatible Dialysis Solutions Preserve Peritoneal Mesothelial Cell and Vessel Wall Integrity. A Case-Control Study on Human Biopsies","volume":"36","author":"Selgas","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","article-title":"Preventing peritoneal membrane fibrosis in peritoneal dialysis patients","volume":"90","author":"Zhou","year":"2016","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1681\/ASN.2009070694","article-title":"The pathophysiology of the peritoneal membrane","volume":"21","author":"Devuyst","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bonomini, M., Masola, V., Procino, G., Zammit, V., Divino-Filho, J.C., Arduini, A., and Gambaro, G. (2021). How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient\u2019s Health). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157955"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3747\/pdi.2016.00228","article-title":"The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the Literature","volume":"37","author":"Grantham","year":"2017","journal-title":"Perit. Dial. Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"868374","DOI":"10.3389\/fphar.2022.868374","article-title":"Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid","volume":"13","author":"Kopytina","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_12","first-page":"280","article-title":"Xylitol as osmotic agent in CAPD: An alternative to glucose for uremic diabetic patients?","volume":"28","author":"Bazzato","year":"1982","journal-title":"Trans.\u2013Am. Soc. Artif. Intern. Organs"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rago, C., Lombardi, T., Di Fulvio, G., Di Liberato, L., Arduini, A., Divino-Filho, J.C., and Bonomini, M. (2021). A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience. Toxins, 13.","DOI":"10.3390\/toxins13030174"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3747\/pdi.2014.00278","article-title":"ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II\u2013Management of Various Cardiovascular Complications","volume":"35","author":"Wang","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: Results of EUROCARE--5-a population-based study","volume":"15","author":"Sant","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"607204","DOI":"10.3389\/fimmu.2021.607204","article-title":"Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions","volume":"12","author":"Terri","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"675363","DOI":"10.3389\/fmed.2021.675363","article-title":"Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 Inflammasome","volume":"8","author":"Luo","year":"2021","journal-title":"Front. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3747\/pdi.2016.00138","article-title":"TNF Signaling in Peritoneal Mesothelial Cells: Pivotal Role of cFLIP(L)","volume":"37","author":"Ludemann","year":"2017","journal-title":"Perit. Dial. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fphar.2015.00113","article-title":"Mesothelial cells in tissue repair and fibrosis","volume":"6","author":"Mutsaers","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.kint.2018.03.014","article-title":"Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis","volume":"94","author":"Raby","year":"2018","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u2019cytokine storm\u2019: Molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11255-004-1562-1","article-title":"Peritoneal catheters and related infections","volume":"37","author":"Thodis","year":"2005","journal-title":"Int. Urol. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"De Waele, J., Lipman, J., Sakr, Y., Marshall, J.C., Vanhems, P., Barrera Groba, C., Leone, M., Vincent, J.L., and Investigators, E.I. (2014). Abdominal infections in the intensive care unit: Characteristics, treatment and determinants of outcome. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-420"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-7922-9-37","article-title":"Complicated intra-abdominal infections worldwide: The definitive data of the CIAOW Study","volume":"9","author":"Sartelli","year":"2014","journal-title":"World J. Emerg. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.kint.2020.01.044","article-title":"Measurement of innate immune response biomarkers in peritoneal dialysis effluent using a rapid diagnostic point-of-care device as a diagnostic indicator of peritonitis","volume":"97","author":"Goodlad","year":"2020","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","article-title":"Biomarker research to improve clinical outcomes of peritoneal dialysis: Consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network","volume":"92","author":"Aufricht","year":"2017","journal-title":"Kidney Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1111\/j.1469-0691.2012.03985.x","article-title":"Coxsackievirus B1 peritonitis in a patient treated with continuous ambulatory peritoneal dialysis: A case report and brief review of the literature","volume":"18","author":"Pauwels","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.dci.2017.01.012","article-title":"Expansion and differentiation of IgM(+) B cells in the rainbow trout peritoneal cavity in response to different antigens","volume":"70","author":"Castro","year":"2017","journal-title":"Dev. Comp. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2009.202","article-title":"Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients","volume":"76","author":"Miles","year":"2009","journal-title":"Kidney Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1038\/s41598-017-06824-6","article-title":"Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice","volume":"7","author":"Tomita","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-Associated Molecular Patterns in Inflammatory Diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune. Netw."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1093\/ndt\/gfr217","article-title":"Human peritoneal mesothelial cells respond to bacterial ligands through a specific subset of Toll-like receptors","volume":"26","author":"Colmont","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.molimm.2007.04.001","article-title":"Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells","volume":"44","author":"Keestra","year":"2007","journal-title":"Mol. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.4049\/jimmunol.167.4.1882","article-title":"Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression","volume":"167","author":"Gewirtz","year":"2001","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11010-008-9957-4","article-title":"Novel role of toll-like receptor 3, RIG-I and MDA5 in poly (I:C) RNA-induced mesothelial inflammation","volume":"322","author":"Wornle","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.matbio.2009.12.002","article-title":"Effect of activation of viral receptors on the gelatinases MMP-2 and MMP-9 in human mesothelial cells","volume":"29","author":"Merkle","year":"2010","journal-title":"Matrix. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","article-title":"Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines","volume":"168","author":"Zarember","year":"2002","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1074-7613(01)00151-0","article-title":"Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation","volume":"14","author":"Hurst","year":"2001","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.immuni.2020.03.011","article-title":"Stromal Cells Covering Omental Fat-Associated Lymphoid Clusters Trigger Formation of Neutrophil Aggregates to Capture Peritoneal Contaminants","volume":"52","author":"Smith","year":"2020","journal-title":"Immunity"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.immuni.2020.03.015","article-title":"Neutrophils Follow Stromal Omens to Limit Peritoneal Inflammation","volume":"52","author":"Buechler","year":"2020","journal-title":"Immunity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3","volume":"181","author":"Fielding","year":"2008","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","article-title":"Directing transition from innate to acquired immunity: Defining a role for IL-6","volume":"175","author":"Jones","year":"2005","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2018-07-859991","article-title":"Differentiation of mesothelial cells into macrophage phagocytic cells in a patient with clinical sepsis","volume":"132","author":"Tirado","year":"2018","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cell.2016.03.009","article-title":"A Reservoir of Mature Cavity Macrophages that Can Rapidly Invade Visceral Organs to Affect Tissue Repair","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/path.5438","article-title":"Control of neutrophil influx during peritonitis by transcriptional cross-regulation of chemokine CXCL1 by IL-17 and IFN-gamma","volume":"251","author":"Catar","year":"2020","journal-title":"J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1007\/s00018-015-1995-y","article-title":"Macrophage polarization in pathology","volume":"72","author":"Sica","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in Tissue Repair, Regeneration, and Fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage Polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu. Rev. Physiol."},{"key":"ref_50","first-page":"225","article-title":"Revisiting mouse peritoneal macrophages: Heterogeneity, development, and function","volume":"6","author":"Bortoluci","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.kint.2016.10.030","article-title":"Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes","volume":"91","author":"Liao","year":"2017","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-3083.1996.d01-297.x","article-title":"Normal human immune peritoneal cells: Subpopulations and functional characteristics","volume":"44","author":"Kubicka","year":"1996","journal-title":"Scand. J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1753425916651330","article-title":"Single-cell analysis reveals new subset markers of murine peritoneal macrophages and highlights macrophage dynamics upon Staphylococcus aureus peritonitis","volume":"22","author":"Accarias","year":"2016","journal-title":"Innate Immun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jlb.57.3.361","article-title":"Review of the macrophage disappearance reaction","volume":"57","author":"Barth","year":"1995","journal-title":"J. Leukoc. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0021-9150(89)90209-8","article-title":"Apolipoprotein A-I inhibits transformation of high density lipoprotein subpopulations during incubation of human plasma","volume":"75","author":"Hopkins","year":"1989","journal-title":"Atherosclerosis"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2022.06.063","article-title":"Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections","volume":"349","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"715209","DOI":"10.3389\/fimmu.2021.715209","article-title":"Ongoing Exposure to Peritoneal Dialysis Fluid Alters Resident Peritoneal Macrophage Phenotype and Activation Propensity","volume":"12","author":"Sutherland","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2017.12.023","article-title":"A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis","volume":"94","author":"Li","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10369","DOI":"10.3390\/ijms140510369","article-title":"The role of peritoneal alternatively activated macrophages in the process of peritoneal fibrosis related to peritoneal dialysis","volume":"14","author":"Wang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/path.5350","article-title":"Inflammatory macrophages switch to CCL17-expressing phenotype and promote peritoneal fibrosis","volume":"250","author":"Chen","year":"2020","journal-title":"J. Pathol."},{"key":"ref_61","first-page":"75","article-title":"In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD","volume":"39","author":"Verbrugh","year":"1993","journal-title":"Clin. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000170261","article-title":"Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis","volume":"14","author":"Fieren","year":"1996","journal-title":"Blood Purif."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/ndt\/gfq771","article-title":"Alternative activation of macrophages in human peritoneum: Implications for peritoneal fibrosis","volume":"26","author":"Bellon","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/25785826.2022.2140503","article-title":"New insights into the metabolism of Th17 cells","volume":"46","author":"Kono","year":"2023","journal-title":"Immunol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ki.2014.33","article-title":"IL-17A is a novel player in dialysis-induced peritoneal damage","volume":"86","author":"Aroeira","year":"2014","journal-title":"Kidney Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4049\/jimmunol.170.4.1958","article-title":"CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism","volume":"170","author":"Chung","year":"2003","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.4049\/jimmunol.1303420","article-title":"Staphylococcus aureus infection of mice expands a population of memory gammadelta T cells that are protective against subsequent infection","volume":"192","author":"Murphy","year":"2014","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Li, J., Zhang, Y., Lou, J., Zhu, J., He, M., Deng, X., and Cai, Z. (2012). Neutralisation of peritoneal IL-17A markedly improves the prognosis of severe septic mice by decreasing neutrophil infiltration and proinflammatory cytokines. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046506"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.ki.5002082","article-title":"Role of mesothelial cell-derived granulocyte colony-stimulating factor in interleukin-17-induced neutrophil accumulation in the peritoneum","volume":"71","author":"Witowski","year":"2007","journal-title":"Kidney Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.4049\/jimmunol.165.10.5814","article-title":"IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells","volume":"165","author":"Witowski","year":"2000","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"416480","DOI":"10.1155\/2015\/416480","article-title":"T Helper 17\/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage","volume":"2015","author":"Liappas","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/MCB.00456-10","article-title":"CD69 association with Jak3\/Stat5 proteins regulates Th17 cell differentiation","volume":"30","author":"Martin","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1681\/ASN.2015080909","article-title":"Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis","volume":"27","author":"Liappas","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s11255-018-1872-3","article-title":"Differences in peritoneal response after exposure to low-GDP bicarbonate\/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model","volume":"50","author":"Keuning","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/j.1525-1594.2010.01000.x","article-title":"Proinflammatory cytokines, hepatocyte growth factor and adipokines in peritoneal dialysis patients","volume":"34","author":"Lee","year":"2010","journal-title":"Artif. Organs."},{"key":"ref_77","first-page":"186","article-title":"Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions","volume":"19","author":"Parikova","year":"2003","journal-title":"Adv. Perit. Dial."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Sanz, A.B., Aroeira, L.S., Bellon, T., del Peso, G., Jimenez-Heffernan, J., Santamaria, B., Sanchez-Nino, M.D., Blanco-Colio, L.M., Lopez-Cabrera, M., and Ruiz-Ortega, M. (2014). TWEAK promotes peritoneal inflammation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090399"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1681\/ASN.2013040332","article-title":"Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients","volume":"24","author":"Lin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1681\/ASN.2005111173","article-title":"Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis","volume":"17","author":"Zareie","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/j.ajkd.2006.11.040","article-title":"Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patients","volume":"49","author":"Alscher","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2017.10.019","article-title":"Natural killer cells play an essential role in resolution of antigen-induced inflammation in mice","volume":"93","author":"Anuforo","year":"2018","journal-title":"Mol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.4049\/jimmunol.1102002","article-title":"Human NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism","volume":"188","author":"Thoren","year":"2012","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.kint.2017.02.006","article-title":"Interferon-gamma production by tubulointerstitial human CD56(bright) natural killer cells contributes to renal fibrosis and chronic kidney disease progression","volume":"92","author":"Law","year":"2017","journal-title":"Kidney Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.1990.8.10.1618","article-title":"Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity","volume":"8","author":"Steis","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/path.1312","article-title":"Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium","volume":"199","author":"Gulyas","year":"2003","journal-title":"J. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-4023-3_3","article-title":"The Role of WT1 in Embryonic Development and Normal Organ Homeostasis","volume":"1467","author":"Wilm","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41419-020-02822-1","article-title":"Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis","volume":"11","author":"Strippoli","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/path.5101","article-title":"Functional molecules in mesothelial-to-mesenchymal transition revealed by transcriptome analyses","volume":"245","author":"Namvar","year":"2018","journal-title":"J. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"44941","DOI":"10.1038\/srep44941","article-title":"Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients","volume":"7","author":"Sandoval","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1681\/ASN.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1681\/ASN.2008101127","article-title":"Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis","volume":"20","author":"Roberts","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.4049\/jimmunol.174.4.2336","article-title":"Conditional macrophage ablation demonstrates that resident macrophages initiate acute peritoneal inflammation","volume":"174","author":"Cailhier","year":"2005","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1177\/089686080902902S03","article-title":"Intrinsic cells: Mesothelial cells -- central players in regulating inflammation and resolution","volume":"29","author":"Yung","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4049\/jimmunol.179.1.514","article-title":"Nod1\/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells","volume":"179","author":"Park","year":"2007","journal-title":"J. Immunol."},{"key":"ref_96","first-page":"1289","article-title":"Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: The role of toll-like receptor 4","volume":"15","author":"Kato","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/089686080502500107","article-title":"Omental milky spots in peritoneal pathophysiology (spots before your eyes)","volume":"25","author":"Beelen","year":"2005","journal-title":"Perit. Dial. Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.immuni.2009.03.014","article-title":"Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens","volume":"30","author":"Carragher","year":"2009","journal-title":"Immunity"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2009.04.005","article-title":"Lymphoid organs for peritoneal cavity immune response: Milky spots","volume":"30","author":"Mebius","year":"2009","journal-title":"Immunity"},{"key":"ref_100","first-page":"26","article-title":"Fibroblastic reticular cells initiate immune responses in visceral adipose tissues and secure peritoneal immunity","volume":"3","author":"Cheng","year":"2018","journal-title":"Sci. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/labinvest.2009.1","article-title":"Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: A key role of IL-1beta stimulation","volume":"89","author":"Witowski","year":"2009","journal-title":"Lab. Investig."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000008704","article-title":"Secretion of IL-6, monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha, and TNFalpha by cultured intact human peritoneum","volume":"31","author":"Riese","year":"1999","journal-title":"Eur. Surg. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"821681","DOI":"10.3389\/fimmu.2022.821681","article-title":"Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy","volume":"13","author":"Catar","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","article-title":"Basic mechanisms and clinical implications of peritoneal fibrosis","volume":"23","author":"Margetts","year":"2003","journal-title":"Perit. Dial. Int."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1681\/ASN.V7102192","article-title":"Establishment and functional characterization of human peritoneal fibroblasts in culture: Regulation of interleukin-6 production by proinflammatory cytokines","volume":"7","author":"Jorres","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0002-9440(10)64095-3","article-title":"Synthesis of C-X-C and C-C chemokines by human peritoneal fibroblasts: Induction by macrophage-derived cytokines","volume":"158","author":"Witowski","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"134708","DOI":"10.1155\/2015\/134708","article-title":"New developments in peritoneal fibroblast biology: Implications for inflammation and fibrosis in peritoneal dialysis","volume":"2015","author":"Witowski","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"590654","DOI":"10.1155\/2014\/590654","article-title":"Regulation of chemokine CCL5 synthesis in human peritoneal fibroblasts: A key role of IFN-gamma","volume":"2014","author":"Kawka","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1007\/s00018-014-1691-3","article-title":"Physiological and pathological consequences of cellular senescence","volume":"71","author":"Burton","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18632\/aging.100871","article-title":"Markers of cellular senescence. Telomere shortening as a marker of cellular senescence","volume":"8","author":"Bernadotte","year":"2016","journal-title":"Aging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: The dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1038\/sj.emboj.7600789","article-title":"C\/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence","volume":"24","author":"Sebastian","year":"2005","journal-title":"EMBO J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/ncb2784","article-title":"A complex secretory program orchestrated by the inflammasome controls paracrine senescence","volume":"15","author":"Acosta","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cyto.2019.01.013","article-title":"The senescence-associated secretory phenotype and its regulation","volume":"117","author":"Rowell","year":"2019","journal-title":"Cytokine"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.arr.2013.01.008","article-title":"Mesothelial cell: A multifaceted model of aging","volume":"12","author":"Ksiazek","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/089686080602600103","article-title":"Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure","volume":"26","author":"Aguilera","year":"2006","journal-title":"Perit. Dial. Int."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Selgas","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3747\/pdi.2017.00244","article-title":"Epithelial-to-Mesenchymal Transition and Migration of Human Peritoneal Mesothelial Cells Undergoing Senescence","volume":"39","author":"Kawka","year":"2019","journal-title":"Perit. Dial. Int."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/089686080302300412","article-title":"Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se","volume":"23","author":"Witowski","year":"2003","journal-title":"Perit. Dial. Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3892\/mmr.2017.6276","article-title":"1,25(OH)2D3\/VDR attenuates high glucose-induced epithelial-mesenchymal transition in human peritoneal mesothelial cells via the TGFbeta\/Smad3 pathway","volume":"15","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000045393","article-title":"High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure","volume":"82","author":"Gotloib","year":"1999","journal-title":"Nephron"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.freeradbiomed.2008.04.032","article-title":"Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells","volume":"45","author":"Ksiazek","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0891-5849(02)01296-0","article-title":"Icodextrin-induced lipid peroxidation disrupts the mesothelial cell cycle engine","volume":"34","author":"Gotloib","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/039139880703000608","article-title":"The use of peritoneal mesothelium as a potential source of adult stem cells","volume":"30","author":"Gotloib","year":"2007","journal-title":"Int. J. Artif. Organs"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1161\/CIRCRESAHA.121.319310","article-title":"Glucose Derivative Induced Vasculopathy in Children on Chronic Peritoneal Dialysis","volume":"129","author":"Bartosova","year":"2021","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/13543784.2016.1196184","article-title":"Targeting inflammation in diabetic kidney disease: Early clinical trials","volume":"25","author":"Sanz","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8050137","DOI":"10.1155\/2022\/8050137","article-title":"Bibliometric Study of Trends in the Diabetic Nephropathy Research Space from 2016 to 2020","volume":"2022","author":"Shao","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_129","first-page":"282","article-title":"Targeting inflammation to treat diabetic kidney disease: The road to 2030","volume":"103","author":"Marchant","year":"2022","journal-title":"Kidney Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jmv.26625","article-title":"The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis","volume":"93","author":"Wang","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"Khunti","year":"2022","journal-title":"Kidney Int."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study","volume":"139","author":"Li","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_135","first-page":"117","article-title":"Empagliflozin in Patients with Chronic Kidney Disease","volume":"388","author":"Group","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"29","author":"Visseren","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2022.08.040","article-title":"A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"103","author":"Bakris","year":"2023","journal-title":"Kidney Int."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: The FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MNH.0000000000000557","article-title":"Mitigating risk of aldosterone in diabetic kidney disease","volume":"29","author":"Persson","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Terami, N., Ogawa, D., Tachibana, H., Hatanaka, T., Wada, J., Nakatsuka, A., Eguchi, J., Horiguchi, C.S., Nishii, N., and Yamada, H. (2014). Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db\/db mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100777"},{"key":"ref_141","first-page":"191","article-title":"Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation","volume":"48","author":"Ishibashi","year":"2016","journal-title":"Horm. Metab. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.kint.2017.12.016","article-title":"The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling","volume":"93","author":"Estrela","year":"2018","journal-title":"Kidney Int."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1080\/13543784.2017.1325872","article-title":"Atrasentan for the treatment of diabetic nephropathy","volume":"26","author":"Egido","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2215\/CJN.13601021","article-title":"Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease","volume":"16","author":"Ortiz","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ckj\/sfz070","article-title":"Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: What was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?","volume":"12","author":"Gorriz","year":"2019","journal-title":"Clin. Kidney J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): A double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1681\/ASN.2018010091","article-title":"DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS","volume":"29","author":"Trachtman","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Vergara, A., Jacobs-Cacha, C., Llorens-Cebria, C., Ortiz, A., Martinez-Diaz, I., Martos, N., Dominguez-Baez, P., Van den Bosch, M.M., Bermejo, S., and Pieper, M.P. (2022). Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112823"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ckj\/sfaa196","article-title":"Complement and protection from tissue injury in COVID-19","volume":"13","author":"Ortiz","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ckj\/sfz142","article-title":"Aliskiren and the dual complement inhibition concept","volume":"13","author":"Ortiz","year":"2020","journal-title":"Clin. Kidney J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1681\/ASN.2021101384","article-title":"Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy","volume":"33","author":"Gao","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"984090","DOI":"10.3389\/fimmu.2022.984090","article-title":"Complement-targeted therapies in kidney transplantation-insights from preclinical studies","volume":"13","author":"Anwar","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/ars.2021.0125","article-title":"The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease","volume":"37","author":"Tan","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the Treatment of ANCA-Associated Vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Lavoz, C., Rayego-Mateos, S., Orejudo, M., Opazo-Rios, L., Marchant, V., Marquez-Exposito, L., Tejera-Munoz, A., Navarro-Gonzalez, J.F., Droguett, A., and Ortiz, A. (2020). Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010272"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Perez-Martinez, J., Perez-Martinez, F.C., Carrion, B., Masia, J., Ortega, A., Simarro, E., Nam-Cha, S.H., and Cena, V. (2012). Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036268"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1744-9987.2011.01031.x","article-title":"Effects of renin-angiotensin-aldosterone system blockade on chlorhexidine gluconate-induced sclerosing encapsulated peritonitis in rats","volume":"16","author":"Kocak","year":"2012","journal-title":"Ther. Apher. Dial."},{"key":"ref_158","first-page":"31","article-title":"Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum","volume":"20","author":"Duman","year":"2004","journal-title":"Adv. Perit. Dial."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/039139880502800212","article-title":"Effect of valsartan versus lisinopril on peritoneal sclerosis in rats","volume":"28","author":"Duman","year":"2005","journal-title":"Int. J. Artif. Organs"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ki.2010.90","article-title":"The renin-angiotensin-aldosterone system in peritoneal dialysis: Is what is good for the kidney also good for the peritoneum?","volume":"78","author":"Nessim","year":"2010","journal-title":"Kidney Int."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","article-title":"Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease","volume":"44","author":"Bonnet","year":"2018","journal-title":"Diabetes Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1008922","DOI":"10.3389\/fcvm.2022.1008922","article-title":"Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials","volume":"9","author":"Scisciola","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Balzer, M.S., Rong, S., Nordlohne, J., Zemtsovski, J.D., Schmidt, S., Stapel, B., Bartosova, M., von Vietinghoff, S., Haller, H., and Schmitt, C.P. (2020). SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate. Biomolecules, 10.","DOI":"10.1101\/2020.11.04.366724"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1681\/ASN.2013070799","article-title":"A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis","volume":"26","author":"Busnadiego","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/labinvest.2014.69","article-title":"The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis","volume":"94","author":"Zhang","year":"2014","journal-title":"Lab. Investig."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"F1084","DOI":"10.1152\/ajprenal.00565.2007","article-title":"Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model","volume":"294","author":"Nishimura","year":"2008","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.5301\/jn.5000306","article-title":"Prevention of lipopolysaccharide-induced peritoneal damage by eplerenone in rats undergoing peritoneal dialysis","volume":"26","author":"Tayama","year":"2013","journal-title":"J. Nephrol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41374-022-00834-3","article-title":"Parthenolide alleviates peritoneal fibrosis by inhibiting inflammation via the NF-kappaB\/ TGF-beta\/Smad signaling axis","volume":"102","author":"Zhang","year":"2022","journal-title":"Lab. Investig."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"106064","DOI":"10.1016\/j.intimp.2019.106064","article-title":"Parthenolide, an NF-kappaB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-beta\/Smad pathway","volume":"78","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ki.2014.209","article-title":"Janus kinase signaling activation mediates peritoneal inflammation and injury in vitro and in vivo in response to dialysate","volume":"86","author":"Dai","year":"2014","journal-title":"Kidney Int."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"F310","DOI":"10.1152\/ajprenal.00428.2016","article-title":"IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2\/STAT3 signaling pathway","volume":"313","author":"Xiao","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1096\/fj.201801111RR","article-title":"Long noncoding RNA AK089579 inhibits epithelial-to-mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA-296-3p via DOK2 in peritoneal fibrosis","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB J."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Kalble, F., Damaske, J., Heide, D., Arnold, I., Richter, F., Maier, O., Eisel, U., Scheurich, P., Pfizenmaier, K., and Zeier, M. (2016). Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163314"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e22632","DOI":"10.1096\/fj.202200784R","article-title":"Inflammatory chemokine (C-C motif) ligand 8 inhibition ameliorates peritoneal fibrosis","volume":"37","author":"Lee","year":"2023","journal-title":"FASEB J"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics","volume":"32","author":"Jope","year":"2007","journal-title":"Neurochem. Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"11737","DOI":"10.7150\/thno.47717","article-title":"Glycogen synthase kinase-3beta: A promising candidate in the fight against fibrosis","volume":"10","author":"Zheng","year":"2020","journal-title":"Theranostics"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"804899","DOI":"10.3389\/fmed.2022.804899","article-title":"Therapeutic Targeting of GSK3beta-Regulated Nrf2 and NFkappaB Signaling Pathways by Salvianolic Acid A Ameliorates Peritoneal Fibrosis","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/scitranslmed.aaz9705","article-title":"Lithium preserves peritoneal membrane integrity by suppressing mesothelial cell alphaB-crystallin","volume":"13","author":"Herzog","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1681\/ASN.2008020211","article-title":"Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane","volume":"20","author":"Aroeira","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1093\/ndt\/gfp384","article-title":"Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis","volume":"24","author":"Fabbrini","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1081\/JDI-120039821","article-title":"Effects of celecoxib on high-sensitivity C-reactive protein in chronic peritoneal dialysis patients","volume":"26","author":"Kim","year":"2004","journal-title":"Ren. Fail."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1004619","DOI":"10.3389\/fphar.2022.1004619","article-title":"Blockade of prostaglandin E2 receptor 4 ameliorates peritoneal dialysis-associated peritoneal fibrosis","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.biopha.2018.05.007","article-title":"Autophagy in health and disease: A comprehensive review","volume":"104","author":"Saha","year":"2018","journal-title":"BioMed Pharm."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jcmm.13393","article-title":"Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis","volume":"22","author":"Wu","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"724141","DOI":"10.3389\/fphar.2021.724141","article-title":"Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis","volume":"12","author":"Shi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1038\/s41598-020-71230-4","article-title":"Trehalose ameliorates peritoneal fibrosis by promoting Snail degradation and inhibiting mesothelial-to-mesenchymal transition in mesothelial cells","volume":"10","author":"Miyake","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.3892\/mmr.2017.7408","article-title":"Effect of 1,25(OH)2D3 on high glucose-induced autophagy inhibition in peritoneum","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.3892\/mmr.2017.7096","article-title":"1,25(OH)2D3 treatment attenuates high glucose-induced peritoneal epithelial to mesenchymal transition in mice","volume":"16","author":"Yang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"468574","DOI":"10.1155\/2015\/468574","article-title":"Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis","volume":"2015","author":"Stavenuiter","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Gonzalez-Mateo, G.T., Fernandez-Millara, V., Bellon, T., Liappas, G., Ruiz-Ortega, M., Lopez-Cabrera, M., Selgas, R., and Aroeira, L.S. (2014). Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0108477"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000339814","article-title":"Impact of rapamycin on peritoneal fibrosis and transport function","volume":"34","author":"Xu","year":"2012","journal-title":"Blood Purif."},{"key":"ref_192","first-page":"989560","article-title":"Rapamycin Protects from Type-I Peritoneal Membrane Failure Inhibiting the Angiogenesis, Lymphangiogenesis, and Endo-MT","volume":"2015","author":"Aguirre","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/febs.13740","article-title":"Rapamycin inhibits epithelial-to-mesenchymal transition of peritoneal mesothelium cells through regulation of Rho GTPases","volume":"283","author":"Xiang","year":"2016","journal-title":"FEBS J."},{"key":"ref_194","first-page":"1473","article-title":"Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Ramil-Gomez, O., Lopez-Pardo, M., Fernandez-Rodriguez, J.A., Rodriguez-Carmona, A., Perez-Lopez, T., Vaamonde-Garcia, C., Perez-Fontan, M., and Lopez-Armada, M.J. (2022). Involvement of Mitochondrial Dysfunction in the Inflammatory Response in Human Mesothelial Cells from Peritoneal Dialysis Effluent. Antioxidants, 11.","DOI":"10.1093\/ndt\/gfac078.049"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Roumeliotis, S., Dounousi, E., Salmas, M., Eleftheriadis, T., and Liakopoulos, V. (2020). Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress. Biomolecules, 10.","DOI":"10.3390\/biom10050768"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"642793","DOI":"10.1155\/2014\/642793","article-title":"High-dialysate-glucose-induced oxidative stress and mitochondrial-mediated apoptosis in human peritoneal mesothelial cells","volume":"2014","author":"Hung","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/0886022X.2022.2126789","article-title":"Activation of AMPK-PGC-1alpha pathway ameliorates peritoneal dialysis related peritoneal fibrosis in mice by enhancing mitochondrial biogenesis","volume":"44","author":"Wu","year":"2022","journal-title":"Ren. Fail."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00795-021-00305-6","article-title":"Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice","volume":"55","author":"Inoue","year":"2022","journal-title":"Med. Mol. Morphol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1096\/fj.201901981R","article-title":"Molecular hydrogen regulates PTEN-AKT-mTOR signaling via ROS to alleviate peritoneal dialysis-related peritoneal fibrosis","volume":"34","author":"Lu","year":"2020","journal-title":"FASEB J."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","article-title":"High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells","volume":"49","author":"Inoguchi","year":"2000","journal-title":"Diabetes"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.kint.2016.01.025","article-title":"Protein kinase C alpha inhibition prevents peritoneal damage in a mouse model of chronic peritoneal exposure to high-glucose dialysate","volume":"89","author":"Wang","year":"2016","journal-title":"Kidney Int."},{"key":"ref_203","first-page":"2931049","article-title":"Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology","volume":"2018","author":"Marchant","year":"2018","journal-title":"Mediators Inflamm."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0896860820938239","article-title":"Peritoneal fibrosis and epigenetic modulation","volume":"41","author":"Wang","year":"2021","journal-title":"Perit. Dial. Int."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/1744-9987.12186","article-title":"Effect of DNA demethylation in experimental encapsulating peritoneal sclerosis","volume":"18","author":"Kim","year":"2014","journal-title":"Ther. Apher. Dial."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Maeda, K., Doi, S., Nakashima, A., Nagai, T., Irifuku, T., Ueno, T., and Masaki, T. (2017). Inhibition of H3K9 methyltransferase G9a ameliorates methylglyoxal-induced peritoneal fibrosis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173706"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Tamura, R., Doi, S., Nakashima, A., Sasaki, K., Maeda, K., Ueno, T., and Masaki, T. (2018). Inhibition of the H3K4 methyltransferase SET7\/9 ameliorates peritoneal fibrosis. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196844"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/path.5352","article-title":"Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis","volume":"250","author":"Shi","year":"2020","journal-title":"J. Pathol."},{"key":"ref_209","first-page":"2746","article-title":"Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-beta1\/Smad3 signaling pathway in vitro","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1038\/s41598-018-26319-2","article-title":"HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal","volume":"8","author":"Rossi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41419-022-05398-0","article-title":"Restoration of WT1\/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells","volume":"13","author":"Bontempi","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3747\/pdi.2013.00089","article-title":"SAHA Suppresses Peritoneal Fibrosis in Mice","volume":"35","author":"Io","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"88730","DOI":"10.18632\/oncotarget.20982","article-title":"Histone deacetylase 6 inhibition counteracts the epithelial-mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"899140","DOI":"10.3389\/fimmu.2022.899140","article-title":"Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"110385","DOI":"10.1016\/j.biopha.2020.110385","article-title":"Noncoding RNAs in peritoneal fibrosis: Background, Mechanism, and Therapeutic Approach","volume":"129","author":"Guo","year":"2020","journal-title":"BioMed Pharm."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trsl.2015.10.009","article-title":"MicroRNA expression profiling in peritoneal fibrosis","volume":"169","author":"Morishita","year":"2016","journal-title":"Transl. Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1111\/jcmm.14029","article-title":"MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41586-020-03148-w","article-title":"Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia","volume":"590","author":"Grant","year":"2021","journal-title":"Nature"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Shankar, P., Singh, J., Joshi, A., Malhotra, A.G., Shrivas, A., Goel, G., Gupta, P., Yadav, J., Saigal, S., and Singh, S. (2022). Organ Involvement in COVID-19: A Molecular Investigation of Autopsied Patients. Microorganisms, 10.","DOI":"10.3390\/microorganisms10071333"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.21037\/apm-20-887","article-title":"Clinical characteristics of coronavirus disease 2019 in Gansu province, China","volume":"9","author":"Yue","year":"2020","journal-title":"Ann. Palliat. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S2213-2600(20)30060-6","article-title":"Coronavirus epidemic: Preparing for extracorporeal organ support in intensive care","volume":"8","author":"Ronco","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of COVID-19 autopsies","volume":"184","author":"Nie","year":"2021","journal-title":"Cell"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: A study based on single-cell transcriptome analysis","volume":"46","author":"Pan","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(20)30068-2","article-title":"Pandemic potential of 2019-nCoV","volume":"20","author":"Thompson","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed Asymptomatic Carrier Transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1681\/ASN.2020030354","article-title":"Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China","volume":"31","author":"Xiong","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40620-020-00732-1","article-title":"on behalf of The Working group of the Piedmont and Aosta Valley Section of the SIN. First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy","volume":"33","author":"Manganaro","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000511390","article-title":"Peritoneal Dialysis Is an Option for Acute Kidney Injury Management in Patients with COVID-19","volume":"50","author":"Madero","year":"2021","journal-title":"Blood Purif."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.07200520","article-title":"COVID-19 in Peritoneal Dialysis Patients","volume":"16","author":"Jiang","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Gagliardi, I., Patella, G., Michael, A., Serra, R., Provenzano, M., and Andreucci, M. (2020). COVID-19 and the Kidney: From Epidemiology to Clinical Practice. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082506"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"752616","DOI":"10.3389\/fmolb.2021.752616","article-title":"Pleural Mesothelial Cells Modulate the Inflammatory\/Profibrotic Response During SARS-CoV-2 Infection","volume":"8","author":"Matusali","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Bobrovitz, N., Ware, H., Ma, X., Li, Z., Hosseini, R., Cao, C., Selemon, A., Whelan, M., Premji, Z., and Issa, H. (2023). Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression. Lancet Infect. Dis.","DOI":"10.1016\/S1473-3099(22)00801-5"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41581-022-00617-5","article-title":"Vaccination in patients with kidney failure: Lessons from COVID-19","volume":"18","author":"Babel","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/L21-0598","article-title":"Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series","volume":"175","author":"Caillard","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"e150175","DOI":"10.1172\/JCI150175","article-title":"Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients","volume":"131","author":"Sattler","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1111\/ajt.16570","article-title":"SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients","volume":"21","author":"Fava","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"eabl6141","DOI":"10.1126\/scitranslmed.abl6141","article-title":"Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients","volume":"14","author":"Charmetant","year":"2022","journal-title":"Sci. Transl. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5763\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:57:37Z","timestamp":1760122657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/6\/5763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":245,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["ijms24065763"],"URL":"https:\/\/doi.org\/10.3390\/ijms24065763","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}